Are “Poop Pills” The Ultimate Bowel Biohack Of The Future?

In this interview segment, Ben Greenfield asks about the risks and candidate suitability for fecal microbiota transplantation (FMT). The expert speaker emphasizes that FMT has an exceptionally high safety profile, having been performed on patients ranging from three‑year‑old children to octogenarians. The only absolute contraindication mentioned is a complete lack of an immune system, not merely low white‑cell counts. The discussion explains how gut‑associated lymphoid tissue interacts with the immune system, leading to reduced food reactivity and increased anti‑inflammatory compounds as the gut heals. A notable case report is highlighted where a patient with severe C. diff infection and celiac‑like gluten sensitivity underwent FMT, which resolved the C. diff infection and appeared to improve the gluten sensitivity, illustrating the broader therapeutic potential of microbiome restoration.










